Molecular targets for the treatment of wounds, in particular chronic wounds

摘要

A therapeutic compound comprising an agent that inhibits the activity of the MAF transcription factor gene, wherein said agent is selected from the group consisting of non-coding DNA or RNA, siRNA, hRNA, TALENS or ribozymes, either naked or in the form of plasmid or viral vectors, antibodies and trametinib, for use in the treatment of chronic wounds.